Preprocedural COVID-19 screening: Do rhinologic patients carry a unique risk burden for false-negative results?

Int Forum Allergy Rhinol. 2020 Oct;10(10):1186-1188. doi: 10.1002/alr.22645. Epub 2020 Jul 15.

Authors

Benjamin S Bleier^{1

2}, Kevin C Welch³

Affiliations

¹ Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, MA.
² Harvard Medical School, Boston, MA.
³ Department of Otolaryngology, Northwestern University Feinberg School of Medicine, Chicago, IL.

No abstract available

Publication types

Letter

MeSH terms

COVID-19 / diagnosis*
COVID-19 Testing / methods*
False Negative Reactions
Humans
Personal Protective Equipment
Rhinitis / diagnosis*
Risk
SARS-CoV-2 / physiology*